Check out which companies are making headlines before the bell on Monday:
McDonald's — The fast food behemoth earned $1.38 per share for the second quarter, two cents below estimates, with revenues also slightly below consensus. Global and U.S. comparable store sales were each up 1 percent, but Europe and the APMEA region posted drops.
Hasbro — The toymaker reported second quarter profit of 29 cents per share, excluding certain items, five cents below estimates, with revenue also missing forecasts. Hasbro saw gains in its Girls, Games, and Preschool categories, but that was not enough to offset sales declines in its Boys products.
Halliburton — The oilfield services provider reported second quarter profit of 73 cents per share, excluding certain items, one cent above estimates. Revenue also beat estimates; much like competitors Schlumberger and Baker Hughes reported last week, Halliburton cited better results outside North America as helping to boost the bottom line.
Cognizant Technology —Goldman Sachs upgraded the stock to "buy" from "neutral", saying the technology services provider's stock has been hurt by concerns over immigration reform and has yet to recover its full value.
Dick's Sporting Goods—The retailer's shares were upgraded to "overweight" from "equal-weight" at Morgan Stanley, which calls Dick's an "undervalued growth story."
Kimberly-Clark — The consumer products maker earned $1.41 per share for the second quarter, excluding certain items, two cents above estimates, helped by improved results in international markets.
Microsoft —Reuters reports that activist shareholder ValueAct Capital Management has held talks with Microsoft directors about its demands for a seat on the board. The stock had its biggest one-day drop in four years on Friday following its quarterly earnings.
Saks — Starwood Capital CEO Barry Sternlicht has reportedly submitted a bid for the retailer, according to the New York Post.
Navistar — Investor Carl Icahn has increased his stake in the heavy equipment maker to 16.55 percent from 15.54 percent.
Apple — Apple is buying transit mapping app maker Hopstop for an undisclosed price. Hopstop was founded in 2005 and has two million monthly active users. Meanwhile, it's primary developer website is shut down after hackers tried to steal information from the site. Apple does say that no customer information was compromised.
Boeing —Boeing continues to be on investors' radar, as the FAA decides to follow the recommendation of British officials and call for inspection of the Emergency Locator Transmitters on Boeing 787 jets.
UBS —The Swiss banking giant has reached a tentative settlement with U.S. authorities of a lawsuit that sought to recover more than $900 million in losses related to mortgage backed securities. No details of the deal, which still needs final approval by both sides, were released.
GlaxoSmithKline —Glaxo issued a statement saying that certain senior executives in its China unit "appear to have acted outside our processes and controls which breaches Chinese law," and that it has "zero tolerance" for such behavior. China officials have been investigated suspicions that doctors and hospitals were bribed to prescribe Glaxo drugs.
AstraZeneca — The company's China offices were visited by Shanghai police, with one employee taken in for questioning. The drugmaker said it was not yet gotten any further updates from officials.
Philips Electronics — The Dutch maker of consumer electronics and appliances reported higher than expected second quarter results, earning 317 million euros for the quarter compared to forecasts of 262 million euros.
Google — The search giant has bought a 6.3 percent stake in a unit of Taiwanese chipmaker Himax Technologies. The unit makes display technologies such as that used in Google Glass.
Himax Technologies —Google has bought a 6.3 percent stake in a unit of the Taiwanese chipmaker. That unit makes display technologies such as that used in Google Glass.
(Read More: See CNBC's Market Insider Blog)
—By CNBC's Peter Schacknow
Questions? Comments? Email us at email@example.com